Clinical and prognostic analysis of unicentric mediastinal Castleman disease: a 10-year retrospective series study.
文献摘要
Background Castleman disease (CD) is a rare lymphoproliferative disorder, and unicentric mediastinal CD (UMCD) represents an uncommon thoracic manifestation for which surgical resection remains the mainstay of treatment.This study aims to: (I) characterize the anatomical distribution of UMCD in a single-center cohort; (II) evaluate the efficacy of video-assisted thoracoscopic surgery (VATS) for UMCD resection and identify preoperative predictors of thoracotomy; (III) analyze prognostic outcomes in surgically managed UMCD patients. Methods A retrospective analysis was conducted on 49 consecutive UMCD patients (26 males, 23 females; mean age 37.27±15.27 years) undergoing surgical resection at the department of thoracic surgery (Tangdu Hospital, Fourth Military Medical University) between May 2014 and October 2024. Demographic characteristics, anatomical distributions, and perioperative outcomes were systematically analyzed. Comparative analysis between VATS and thoracotomy groups was performed using independent samples t-tests. Univariate and multivariate logistic regression identified predictors of thoracotomy, with diagnostic performance evaluated via receiver operating characteristic (ROC) curve analysis. Survival outcomes were assessed using Kaplan-Meier methodology. Results The most frequent anatomical involvement occurred in station 3A lymph nodes (12 cases, 24.5%), followed by station 10 (11 cases, 22.3%) and station 4 (8 cases, 16.3%). Mean tumor size was 6.25±3.09 cm (intraoperative measurement). Histopathological subtypes included hyaline vascular variant (43 cases, 87.7%), plasma cell variant (4 cases, 8.2%), and mixed-type (2 cases, 4.1%). Compared to thoracotomy, VATS demonstrated shorter operative duration (P vs. 5.52±3.54 days, P 6.6 cm (P 102 Hounsfield units (HU) (P Conclusions Station 3A lymph nodes represent the predominant anatomical site of UMCD involvement. VATS resection confers significant advantages over thoracotomy, including reduced operative time, blood loss, and postoperative recovery duration. The diameter >6.6 cm and arterial-phase CT attenuation >102 HU of tumors serve as reliable preoperative indicators for thoracotomy. Early surgical intervention correlates with favorable prognosis, while postoperative complications and local recurrence demonstrate significant association with mortality.